GUIDEPOINT INSIGHTS ASCO 2023 COVERAGE

Join us, June 3rd-6th, as Guidepoint Insights hosts a large in-person group meeting at the 2023 ASCO Conference (live event only, no transcript) featuring KOLs who will dive deeper into clinical updates on major disease sites and research areas.

Dates:
Saturday, June 3, 2023 – Tuesday, June 6, 2023

Venue:
VU Rooftop Bar, 133 E Cermak Rd, Chicago, IL 60616

In-Person Group Meetings

Group meetings will not be recorded and transcripts will not be available after the event.

For more details on our ASCO events, please email Alyssa Vozza at avozza@guidepoint.com.

 

Please select the group meetings you would like to participate in by completing the form below and clicking “submit” at the bottom of the page.

 

    Saturday, June 3rd
    (60-Minute Group Meetings - Live Event Only, No Transcript)
    10:00 AM CT - Jason Luke // In-Person
    Immunotherapy | Associate Professor, University of Pittsburgh School of Medicine
    10:00 AM CT - Jared Weiss // *Virtual Zoom*
    NSCLC and Head and Neck Cancer | Advocate, Lung Cancer Initiative of North Carolina
    11:00 AM CT - Vamsidhar Velcheti // In-Person
    NSCLC | Director for Thoracic Oncology Program, NYU Langone Hospitals
    11:00 AM CT - Joshua Sasine // *Virtual Zoom*
    Cell Therapies and Hem | Assistant Professor of Medicine, Founder and Co-Director of the CAR T Program, Cedars-Sinai Health System
    12:00 PM CT - Elisabet Manasanch // In-Person
    Multiple Myeloma | Associate Professor, The University of Texas M. D. Anderson Cancer Center
    1:00 PM CT - Michael Morse // In-Person
    GI Cancer | Attending Physician, Duke University Health System Inc.
    1:00 PM CT - Brian Mulherin // In-Person
    Solid Tumor | Consultant, Self Employed
    2:00 PM CT - Prithviraj Bose // In-Person
    MPN, MF, MDS | Associate Professor, The University of Texas M. D. Anderson Cancer Center
    2:00 PM CT - Premal Thaker // In-Person
    GYN | Associate Professor in Gynecologic Oncology, Washington University, St. LouisCenter
    3:00 PM CT - Abdul Mundia // In-Person
    Leukemias | Professor of Medicine, Mount Sinai Health System Inc.
    3:00 PM CT - Patrick Forde // In-Person
    NSCLC | Director, Thoracic Oncology Research Program, Johns Hopkins School of Medicine
    Sunday, June 4th
    (60-Minute Group Meetings - Live Event Only, No Transcript)
    9:00 AM CT - Chris Vaklavas // In-Person
    Breast Cancer | Associate Professor, Huntsman Cancer Institute, The University of Utah
    9:00 AM CT - Koichi Takahashi // In-Person
    AML | Hematologic Oncologist at The University of Texas M. D. Anderson Cancer Center
    10:00 AM CT - Eric Jonasch // In-Person
    GU Cancer | Professor, Department of Genitourinary Medical Oncology for the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center
    10:00 AM CT - Ran Reshef // In-Person
    CAR-Ts and Transplant | Director of Translational Research, Blood and Marrow Transplantation Clinical Lead, CAR-T Cell Program, Associate Professor of Medicine, Columbia University Medical Center
    11:00 AM CT - Timothy Yap // In-Person
    Gyn and DDR Therapies | Medical Director, The University of Texas MD Anderson Cancer Center
    11:00 AM CT - Michael Birrer // In-Person
    GYN | Vice Chancellor at The Winthrop P. Rockefeller Cancer Institute At UAMS
    12:00 PM CT - Thomas Marron // In-Person
    Solid Tumors | Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai
    12:00 PM CT - Joshua Brody // *Hybrid*
    Lymphomas | Associate Professor in Hematology and Medical Oncology & Director of the Lymphoma Immunotherapy Program, Mount Sinai Medical Center Inc.
    1:00 PM CT - Matthew Smith // In-Person
    GU Cancer | Director of Genitourinary Malignancies Program, The General Hospital Corporation
    1:00 PM CT - Ossama Maher // *Virtual Zoom*
    pLGG | Associate Medical Director of Bone Marrow Transplant, Kidz Medical Service
    1:00 PM CT - Ravi Vij // In-Person
    Multiple Myeloma | Founder, MyCancerHaven
    2:00 PM CT - Victoria Wang // In-Person
    Lung | Oncologist/Assistant Professor, The University of California, San Francisco
    2:00 PM CT - Rodabe Amaria // In-Person
    Melanoma and TILs | Associate Professor, Department of Melanoma Oncology, The University of Texas M. D. Anderson Cancer Center
    3:00 PM CT - Konstantin Dragnev // *Hybrid*
    NSCLC | Associate Director for Clinical Research, Norris Cotton Cancer Center
    3:00 PM CT - Tu Dan // In-Person
    pLGG | Assistant Professor, The University of Texas Southwestern Medical Center
    4:00 PM CT - Neil Vasan // *Virtual Zoom*
    Breast Cancer | Assistant Professor, Columbia University
    Monday, June 5th
    (60-Minute Group Meetings - Live Event Only, No Transcript)
    8:00 AM CT - Scott Tagawa // *Virtual Zoom*
    GU Cancer | Professor of Medicine & Urology, Weill Cornell Medical College, New York
    9:00 AM CT - Bradley Hunter // *Virtual Zoom*
    Cell Therapies and Hem | Director, Immune Effector Cell Therapy, attending physician, Bone Marrow Transplant and Medical Oncology, Intermountain Health Care Inc.
    9:00 AM CT - Hatim Husain // In-Person
    NSCLC and Novel Therapies | Associate Professor of Medical Oncology, University of California - San Diego
    10:00 AM CT - Giancarlo Moscol // In-Person
    Breast Cancer | Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center
    10:00 AM CT - Aurelien Marabelle // *Hybrid*
    Immunotherapy | Professor, University of Paris-Saclay
    11:00 AM CT - Saurabh Dahiya // *Virtual Zoom*
    Lymphomas and Multiple Myeloma | Associate Professor of Medicine; Clinical Director of Cancer Cell Therapy, Stanford University
    11:00 AM CT - Ryan Corcoran // *Hybrid*
    GI/KRAS | Co-founder and Board of Directors Member, Alterome Therapeutics Inc.
    12:00 PM CT - Joshua Sabari // *Hybrid*
    Lung | Medical Oncologist, NYU Langone Medical Center LLC
    12:00 PM CT - Tanguy Seiwert // In-Person
    Head and Neck Cancer | Assistant Professor and Director of Head and Neck Oncology Disease Group, Johns Hopkins University
    1:00 PM CT - Salman Punekar // In-Person
    Lung and Sarcomas | Assistant Professor of Medicine, NYU Langone Health System
    1:00 PM CT - Namrata Vijayvergia // In-Person
    GI Cancer | Assistant Professor, Hematology and Oncology, Fox Chase Cancer Center Medical Group Inc.
    1:00 PM CT - Justin Kaner // *Virtual Zoom*
    MPN, MF, MDS | Assistant Professor, Weill Cornell Medicine
    2:00 PM CT - Matthew Frigault // *Hybrid*
    CAR-Ts | Assistant Professor, Harvard Medical School
    3:00 PM CT - Neil Lyengar // In-Person
    Breast Cancer | Associate Physician at Rockefeller University
    3:00 PM CT - Benjamin Gartrell // In-Person
    GU Cancer | Director of Genitourinary Oncology, Associate Professor of Oncology and Urology, Montefiore Health System Inc.
    Tuesday, June 6th
    (60-Minute Group Meetings - Live Event Only, No Transcript)
    8:00 AM CT - Timothy Yap // *Virtual Zoom*
    Gyn and DDR Therapies | Medical Director, The University of Texas MD Anderson Cancer Center
    12:00 PM CT - David Sallman // *Virtual Zoom*
    AML | Assistant Member, H. Lee Moffitt Cancer Center & Research Institute Inc.
    2:00 PM CT - Paul Disilvestro // *Virtual Zoom*
    GYN | Professor, Brown University

    Related Teleconferences

    JUNE 5 | 8:30 AM ET
    ASCO 2023: Day One Biopharmaceuticals — A Discussion on the Registrational FIREFLY-1 Data With Dr. Adam Green
    Associate Professor of Pediatrics, University of Colorado School of Medicine
    SIGN UP
    MAY 31 | 2:00 PM ET
    Pre-ASCO 2023: Day One Biopharmaceuticals — FIREFLY-1 Abstract Review
    Assistant Professor, Albany Medical Center
    SIGN UP
    MAY 30 | 11:00 AM ET
    Pre-ASCO 2023: Previewing the TROP2 and EGFR NSCLC Updates With Dr. Thai Ho
    Associate Professor of Medicine in the Division of Hematology and Oncology, Mayo Clinic Arizona
    SIGN UP
    MAY 26 | 12:00 PM ET
    Pre-ASCO 2023: Day One Biopharmaceuticals — Previewing Registrational FIREFLY-1 Data
    Medical Director and Radiation Oncologist, Allegheny Health Network
    SIGN UP
    MAY 26 | 11:30 AM ET
    Pre-ASCO 2023: Previewing TROP2 and EGFR NSCLC Updates With Dr. Konstantin Dragnev
    Associate Director for Clinical Research, Dartmouth Cancer Center
    SIGN UP
    MAY 23 | 1:00 PM ET
    Pre-ASCO 2023: Breast Cancer — Previewing ADC Updates With Dr. Kathleen Harnden
    Director of the Breast Medical Oncology Program, Inova Health System
    SIGNUP
    MAY 19 | 10:00 AM ET
    Pre-ASCO 2023: Breast Cancer — Reviewing the Competitive Landscape of Oral SERDs and PROTACs With Dr. Jules Cohen
    Medical Oncologist and Associate Professor of Clinical Medicine, Stony Brook University Medical Center
    SIGN UP
    MAY 17 | 11:00 AM ET
    Pre-ASCO 2023: Breast Cancer — Reviewing the Competitive Landscape of Oral SERDs and PROTACs With Dr. Chris Vaklavas
    Medical Associate Professor, Huntsman Cancer Institute
    SIGN UP
    MAY 17 | 11:00 AM ET
    Pre-ASCO 2023: Previewing RCC and UC Updates With Scott Tagawa, MD
    Professor of Medicine and Urology, Weill Cornell Medicine
    SIGN UP
    MAY 15 | 12:00 PM ET
    Pre-ASCO 2023: Folate Receptor Alpha, NaPi2b, and WEE1 — Updates for Ovarian Cancer Treatment
    Associate Professor of Obstetrics and Gynecology & Director of the Gynecologic Oncology Fellowship Program, NYU Langone Health
    SIGN UP
    MAY 15 | 11:00 AM ET
    CLL: BTKi and Pipeline Prospects with Dr. Nam Dang Ahead of EHA and ASCO
    Deputy Chief of the Division of Hematology/Oncology and Director of Cancer Clinical trials, University of Florida
    SIGN UP
    MAY 15 | 10:00 AM ET
    Pre-ASCO 2023: Previewing TROP2 and EGFR NSCLC Updates With Dr. Hatim Husain
    Associate Professor of Medical Oncology, University of California – San Diego
    SIGN UP
    MAY 15 | 9:00 AM ET
    Myelofibrosis: A Discussion on Vonjo Uptake and Pipeline Prospects Like Momelotinib, Pelabrasib, and Others Ahead of EHA and ASCO 2023 With Prithviraj Bose, MD
    Associate Professor, University of Texas MD Anderson Cancer Center
    SIGN UP
    MAY 10
    Pre-ASCO 2023: Previewing the TROP2 and EGFR NSCLC Updates With Dr. Thomas Marron
    Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai
    REQUEST
    MAY 9
    Multiple Myeloma: Discussion With Dr. Marc Braunstein Ahead of ASCO and EHA 2023
    Hematologist/Medical Oncologist and Clinical Assistant Professor, NYU Langone Medical Center
    REQUEST
    MAY 9
    Pre-ASCO 2023: Mersana Therapeutics and Sutro Biopharma — Updates for Ovarian Cancer
    Assistant Professor of Gynecologic Oncology, Northwestern University Feinberg School of Medicine
    REQUEST
    MAY 5
    DLBCL: Discussing CD3xCD20 With Dr. Nam Dang Ahead of ASCO and EHA
    Professor of Medicine and Deputy Chief of the Division of Hematology & Oncology, University of Florida
    REQUEST
    MAY 4
    Pre-ASCO 2023: Previewing the TROPION-Lung Results for Dato-DXd With Dr. Tanguy Seiwert
    Assistant Professor of Oncology & Director of the Head and Neck Cancer Oncology Disease Group, Johns Hopkins University
    REQUEST
    MAY 1
    Previewing ASCO 2023 Updates on FRα and NaPi2b ADCs in Ovarian Cancer
    President of Medicine and Science, Cancer Treatment Centers of America (formerly Cancer Treatment Centers of America)
    REQUEST
    MAY 1
    Pre-ASCO 2023: The Allogeneic CAR-T Landscape
    Chief of Hematology and Director of BMT & Cell Therapy, USC Keck School of Medicine
    REQUEST
    APRIL 28
    Previewing PSMA and PARP Inhibitors’ ASCO 2023 Updates and Expectations for Lynparza’s AdCom Meeting
    Associate Professor of Urology, Tufts University School of Medicine
    REQUEST
    APRIL 28
    Previewing ASCO KRAS Updates and Reviewing AACR Updates From Eli Lilly, Roche, and More With Brian Mulherin, MD
    Hematologist/Oncologist and Consultant, Hematology Oncology of Indiana
    REQUEST
    APRIL 28
    Pre-ASCO 2023 Blueprint Medicine: Discussion with Dr. Konstantin Dragnev on BPMC EGFR NSCLC Pipeline (BLU-945, BLU-525, and BLU-451) and Relevant Abstracts
    Associate Director for Clinical Research, Dartmouth Cancer Center
    REQUEST
    APRIL 27
    Pre-ASCO 2023: Johnson & Johnson and Legend Biotech — Previewing the Full Data From the Carvytki CARTITUDE-4 Study
    Assistant Professor of Medicine in Hematology and Medical Oncology & Co-Director of CAR T and Stem Cell Transplant at the Center of Excellence for Multiple Myeloma, Icahn School of Medicine at Mount Sinai
    REQUEST